ESPR Other Income/Expenses (Net)
Esperion Therapeutics Inc · Other Income/Expenses (Net)
ESPR Other Income/Expenses (Net)
Latest reported-$18.62Mperiod ending
ESPR Quarterly Other Income/Expenses (Net) ($152.61K → -$18.62M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
ESPR other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -18,615,000 | |
| -21,561,000 | |
| -21,374,000 | |
| -19,820,000 | |
| -18,359,000 | |
| -16,898,000 | |
| -13,498,000 | |
| -64,504,000 | |
| -11,247,000 | |
| -13,977,000 | |
| -13,717,000 | |
| -12,877,000 | |
| -13,114,000 | |
| -12,974,000 | |
| -13,494,000 | |
| -13,948,000 | |
| -13,742,000 | |
| -9,491,000 | |
| -13,641,000 | |
| -11,135,000 | |
| -8,111,000 | |
| -8,907,000 | |
| -4,886,000 | |
| -4,559,000 | |
| -3,803,000 | |
| -2,982,000 | |
| -2,609,000 | |
| 1,077,000 | |
| 450,000 | |
| 610,000 | |
| 651,000 | |
| 750,000 | |
| 764,000 | |
| 805,000 | |
| 518,000 | |
| 323,000 | |
| 348,000 | |
| 329,000 | |
| 310,000 | |
| 296,000 | |
| 237,000 | |
| 112,000 | |
| 118,000 | |
| 67,000 | |
| -41,000 | |
| -77,000 | |
| -106,000 | |
| 16,000 | |
| 16,000 | |
| 47,000 | |
| 169,000 | |
| -2,649,000 | |
| -895,000 | |
| -615,309 | |
| -361,025 | |
| -302,273 | |
| -259,369 | |
| -342,000 | |
| -602,000 | |
| -317,000 | |
| -422,000 | |
| 113,000 | |
| -518,000 | |
| 47,000 | |
| 307,000 | |
| 226,000 | |
| 2,612,000 | |
| 3,080,000 | |
| -1,055,000 | |
| -3,429,000 | |
| 309,000 | |
| 152,608 |